logo
  

Commerzbank Sells Real Estate Loan Portfolios Worth EUR 2.9 Bln - Quick Facts

Commerzbank (CRZBY.PK) said it has sold a loan portfolios worth 2.9 billion euros or $3.22 billion as it continues to streamline its balance sheet and free up capital to comply with tougher bank rules.

The company said it sold real estate loans in Central and Eastern Europe, Scandinavia and Turkey worth 2.2 billion euros to JP Morgan and Lone Star, while a portfolio of non-performing German mortgages worth 700 million euros went to Oaktree.

Commerzbank said it expects charges of 65 million euros in the second quarter as well as 20 million euros in the third quarter from the sale.

Commerzbank has shrunk underperforming assets in its internal "bad bank" created in the wake of the financial crisis faster than planned, boosting reform efforts led by Chief Executive Martin Blessing.

Commerzbank aims to reduce its current holdings of 30 billion euros in shipping credits and real estate assets to below 20 billion by end-2016.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT